Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.50M | 1.59M | 1.98M | 2.27M | 2.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.50M | 1.59M | 1.98M | 2.27M | 2.00M |
| Cost of Revenue | 1.17M | 1.05M | 1.18M | 2.12M | 2.01M |
| Gross Profit | 322.60K | 533.50K | 799.60K | 156.70K | -9.10K |
| SG&A Expenses | 7.30M | 6.68M | 8.94M | 6.46M | 6.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.69M | 8.94M | 11.48M | 9.83M | 9.63M |
| Operating Income | -8.20M | -7.35M | -9.50M | -7.56M | -7.63M |
| Income Before Tax | -30.72M | -30.53M | -29.31M | -23.87M | -22.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.72 | -30.53 | -29.31 | -23.87 | -22.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.72M | -30.53M | -29.31M | -23.87M | -22.70M |
| EBIT | -8.20M | -7.35M | -9.50M | -7.56M | -7.63M |
| EBITDA | -7.98M | -7.19M | -9.39M | -7.42M | -7.52M |
| EPS Basic | -0.98 | -1.40 | -1.65 | -1.70 | -1.85 |
| Normalized Basic EPS | -0.44 | -0.59 | -0.78 | -0.95 | -0.98 |
| EPS Diluted | -0.98 | -1.40 | -1.65 | -1.70 | -1.85 |
| Normalized Diluted EPS | -0.44 | -0.59 | -0.78 | -0.95 | -0.98 |
| Average Basic Shares Outstanding | 145.28M | 113.33M | 89.36M | 69.97M | 59.39M |
| Average Diluted Shares Outstanding | 145.28M | 113.33M | 89.36M | 69.97M | 59.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |